You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 7, 2024

Investigational Drug Information for PF-07321332


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for PF-07321332?

PF-07321332 is an investigational drug.

There have been 21 clinical trials for PF-07321332. The most recent clinical trial was a Phase 1 trial, which was initiated on July 16th 2021.

The most common disease conditions in clinical trials are COVID-19, Renal Insufficiency, and Liver Diseases. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There is one US patent protecting this investigational drug and forty-four international patents.

Recent Clinical Trials for PF-07321332
TitleSponsorPhase
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine RosuvastatinPfizerPhase 1
Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.PfizerPhase 1
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney DiseasePfizerPhase 1

See all PF-07321332 clinical trials

Clinical Trial Summary for PF-07321332

Top disease conditions for PF-07321332
Top clinical trial sponsors for PF-07321332

See all PF-07321332 clinical trials

International Patents for PF-07321332

Drugname Country Document Number Estimated Expiration Related US Patent
PF-07321332 Argentina AR123111 2040-09-03 ⤷  Sign Up
PF-07321332 Australia AU2021266232 2040-09-03 ⤷  Sign Up
PF-07321332 Australia AU2022202158 2040-09-03 ⤷  Sign Up
PF-07321332 Australia AU2022221493 2040-09-03 ⤷  Sign Up
PF-07321332 Brazil BR112021022419 2040-09-03 ⤷  Sign Up
PF-07321332 Canada CA3137824 2040-09-03 ⤷  Sign Up
PF-07321332 Chile CL2021002965 2040-09-03 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.